{"entity":{"type":"insider","cik":"0001886575","url":"/insider/0001886575","json_url":"/insider/0001886575.json","name":"Betz Stephen F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":53,"n_filings":48,"first":"2021-10-25","last":"2026-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Betz Stephen F.","source":"filing","n_filings":48,"first_seen":"2021-10-25","last_seen":"2026-03-18"}],"transactions":[{"id":5766756,"accession":"0001628280-26-019498","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-019498","line_url":"/filing/0001628280-26-019498","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10612.0,"shares_display":"10,612","price_per_share":37.373763663776856,"price_display":"37.37","price_state":"stated","total_value":396610.38,"total_display":"396,610.38","total_whole":"396,610","shares_owned_after":141342.0,"shares_owned_after_display":"141,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":4313567,"accession":"0000950170-25-086804","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-086804","line_url":"/filing/0000950170-25-086804#line-3","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97483.0,"shares_display":"97,483","price_per_share":32.23,"price_display":"32.23","price_state":"stated","total_value":3141877.09,"total_display":"3,141,877.09","total_whole":"3,141,877","shares_owned_after":99713.0,"shares_owned_after_display":"99,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-12","filed_date":"2025-06-16","scope":"insider"},{"id":4583456,"accession":"0000950170-25-043402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043402","line_url":"/filing/0000950170-25-043402","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5770.0,"shares_display":"5,770","price_per_share":34.20328596187175,"price_display":"34.20","price_state":"stated","total_value":197352.96,"total_display":"197,352.96","total_whole":"197,353","shares_owned_after":108879.0,"shares_owned_after_display":"108,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider","n_lines":2},{"id":2679937,"accession":"0000950170-24-105952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105952","line_url":"/filing/0000950170-24-105952#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1035.0,"shares_display":"1,035","price_per_share":51.5,"price_display":"51.50","price_state":"stated","total_value":53302.5,"total_display":"53,302.50","total_whole":"53,303","shares_owned_after":68576.0,"shares_owned_after_display":"68,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":3216742,"accession":"0000950170-24-101434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-101434","line_url":"/filing/0000950170-24-101434#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":53.19,"price_display":"53.19","price_state":"stated","total_value":159570.0,"total_display":"159,570.00","total_whole":"159,570","shares_owned_after":69611.0,"shares_owned_after_display":"69,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":3216379,"accession":"0000950170-24-097085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-097085","line_url":"/filing/0000950170-24-097085#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":47.68,"price_display":"47.68","price_state":"stated","total_value":143040.0,"total_display":"143,040.00","total_whole":"143,040","shares_owned_after":72611.0,"shares_owned_after_display":"72,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":2037514,"accession":"0000950170-24-086935","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-086935","line_url":"/filing/0000950170-24-086935#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":53.43,"price_display":"53.43","price_state":"stated","total_value":160290.0,"total_display":"160,290.00","total_whole":"160,290","shares_owned_after":75611.0,"shares_owned_after_display":"75,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-25","filed_date":"2024-07-26","scope":"insider"},{"id":2117251,"accession":"0000950170-24-083221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-083221","line_url":"/filing/0000950170-24-083221#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":48.55,"price_display":"48.55","price_state":"stated","total_value":145650.0,"total_display":"145,650.00","total_whole":"145,650","shares_owned_after":78611.0,"shares_owned_after_display":"78,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":3215487,"accession":"0000950170-24-077905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-077905","line_url":"/filing/0000950170-24-077905#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":45.37,"price_display":"45.37","price_state":"stated","total_value":136110.0,"total_display":"136,110.00","total_whole":"136,110","shares_owned_after":80643.0,"shares_owned_after_display":"80,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-06-26","scope":"insider"},{"id":3020877,"accession":"0000950170-24-071971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-071971","line_url":"/filing/0000950170-24-071971#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":43.86,"price_display":"43.86","price_state":"stated","total_value":131580.0,"total_display":"131,580.00","total_whole":"131,580","shares_owned_after":83643.0,"shares_owned_after_display":"83,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":3254585,"accession":"0000950170-24-066657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-066657","line_url":"/filing/0000950170-24-066657#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":47.49,"price_display":"47.49","price_state":"stated","total_value":142470.0,"total_display":"142,470.00","total_whole":"142,470","shares_owned_after":86643.0,"shares_owned_after_display":"86,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":2736003,"accession":"0000950170-24-059865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-059865","line_url":"/filing/0000950170-24-059865#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":49.43,"price_display":"49.43","price_state":"stated","total_value":148290.0,"total_display":"148,290.00","total_whole":"148,290","shares_owned_after":89643.0,"shares_owned_after_display":"89,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-14","scope":"insider"},{"id":2981769,"accession":"0001209191-24-002314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002314","line_url":"/filing/0001209191-24-002314#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":37.26,"price_display":"37.26","price_state":"stated","total_value":111780.0,"total_display":"111,780.00","total_whole":"111,780","shares_owned_after":73298.0,"shares_owned_after_display":"73,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider"},{"id":2916179,"accession":"0001209191-24-001510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-001510","line_url":"/filing/0001209191-24-001510#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":37.65,"price_display":"37.65","price_state":"stated","total_value":112950.0,"total_display":"112,950.00","total_whole":"112,950","shares_owned_after":76298.0,"shares_owned_after_display":"76,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-12","scope":"insider"},{"id":8585707,"accession":"0001209191-23-059809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059809","line_url":"/filing/0001209191-23-059809#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":35.89,"price_display":"35.89","price_state":"stated","total_value":107670.0,"total_display":"107,670.00","total_whole":"107,670","shares_owned_after":79298.0,"shares_owned_after_display":"79,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-27","scope":"insider"},{"id":8631243,"accession":"0001209191-23-058503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058503","line_url":"/filing/0001209191-23-058503#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":32.87,"price_display":"32.87","price_state":"stated","total_value":98610.0,"total_display":"98,610.00","total_whole":"98,610","shares_owned_after":82298.0,"shares_owned_after_display":"82,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-13","scope":"insider"},{"id":7836991,"accession":"0001209191-23-056904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056904","line_url":"/filing/0001209191-23-056904#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.84,"price_display":"31.84","price_state":"stated","total_value":95520.0,"total_display":"95,520.00","total_whole":"95,520","shares_owned_after":85298.0,"shares_owned_after_display":"85,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":8070143,"accession":"0001209191-23-006872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006872","line_url":"/filing/0001209191-23-006872#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":19.59,"price_display":"19.59","price_state":"stated","total_value":61238.34,"total_display":"61,238.34","total_whole":"61,238","shares_owned_after":64689.0,"shares_owned_after_display":"64,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":8324876,"accession":"0001209191-23-005252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005252","line_url":"/filing/0001209191-23-005252#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8336.0,"shares_display":"8,336","price_per_share":21.07,"price_display":"21.07","price_state":"stated","total_value":175639.52,"total_display":"175,639.52","total_whole":"175,640","shares_owned_after":67815.0,"shares_owned_after_display":"67,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-27","scope":"insider"},{"id":8151029,"accession":"0001209191-23-004021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004021","line_url":"/filing/0001209191-23-004021#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":56268.0,"total_display":"56,268.00","total_whole":"56,268","shares_owned_after":76151.0,"shares_owned_after_display":"76,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":8700957,"accession":"0001209191-23-001846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-001846","line_url":"/filing/0001209191-23-001846#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":18.35,"price_display":"18.35","price_state":"stated","total_value":57362.1,"total_display":"57,362.10","total_whole":"57,362","shares_owned_after":79277.0,"shares_owned_after_display":"79,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6614255,"accession":"0001209191-22-061986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061986","line_url":"/filing/0001209191-22-061986#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":50016.0,"total_display":"50,016.00","total_whole":"50,016","shares_owned_after":82403.0,"shares_owned_after_display":"82,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6150435,"accession":"0001209191-22-059779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059779","line_url":"/filing/0001209191-22-059779#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":17.84,"price_display":"17.84","price_state":"stated","total_value":55767.84,"total_display":"55,767.84","total_whole":"55,768","shares_owned_after":84968.0,"shares_owned_after_display":"84,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6957583,"accession":"0001209191-22-057585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057585","line_url":"/filing/0001209191-22-057585#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":18.72,"price_display":"18.72","price_state":"stated","total_value":58518.72,"total_display":"58,518.72","total_whole":"58,519","shares_owned_after":88094.0,"shares_owned_after_display":"88,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6894312,"accession":"0001209191-22-055522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055522","line_url":"/filing/0001209191-22-055522#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":18.52,"price_display":"18.52","price_state":"stated","total_value":57893.52,"total_display":"57,893.52","total_whole":"57,894","shares_owned_after":91220.0,"shares_owned_after_display":"91,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6212781,"accession":"0001209191-22-054104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054104","line_url":"/filing/0001209191-22-054104#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":17.73,"price_display":"17.73","price_state":"stated","total_value":55423.98,"total_display":"55,423.98","total_whole":"55,424","shares_owned_after":94346.0,"shares_owned_after_display":"94,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-19","scope":"insider"},{"id":6894069,"accession":"0001209191-22-052769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052769","line_url":"/filing/0001209191-22-052769#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":61394.64,"total_display":"61,394.64","total_whole":"61,395","shares_owned_after":97472.0,"shares_owned_after_display":"97,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6613385,"accession":"0001209191-22-050529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-050529","line_url":"/filing/0001209191-22-050529#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4168.0,"shares_display":"4,168","price_per_share":21.01,"price_display":"21.01","price_state":"stated","total_value":87569.68,"total_display":"87,569.68","total_whole":"87,570","shares_owned_after":100598.0,"shares_owned_after_display":"100,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6631750,"accession":"0001209191-22-049311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-049311","line_url":"/filing/0001209191-22-049311#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1042.0,"shares_display":"1,042","price_per_share":21.0017,"price_display":"21.00","price_state":"stated","total_value":21883.7714,"total_display":"21,883.77","total_whole":"21,884","shares_owned_after":104766.0,"shares_owned_after_display":"104,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-09","scope":"insider"},{"id":6574282,"accession":"0001209191-22-048734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048734","line_url":"/filing/0001209191-22-048734#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3126.0,"shares_display":"3,126","price_per_share":18.59,"price_display":"18.59","price_state":"stated","total_value":58112.34,"total_display":"58,112.34","total_whole":"58,112","shares_owned_after":105808.0,"shares_owned_after_display":"105,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6573003,"accession":"0001209191-22-027145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-027145","line_url":"/filing/0001209191-22-027145#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3247.0,"shares_display":"3,247","price_per_share":20.096,"price_display":"20.10","price_state":"stated","total_value":65251.712,"total_display":"65,251.71","total_whole":"65,252","shares_owned_after":107598.0,"shares_owned_after_display":"107,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6351622,"accession":"0001209191-22-025190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025190","line_url":"/filing/0001209191-22-025190#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5664.0,"shares_display":"5,664","price_per_share":25.81,"price_display":"25.81","price_state":"stated","total_value":146187.84,"total_display":"146,187.84","total_whole":"146,188","shares_owned_after":110845.0,"shares_owned_after_display":"110,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-21","scope":"insider"},{"id":6295801,"accession":"0001209191-22-023556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023556","line_url":"/filing/0001209191-22-023556#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":23.9735,"price_display":"23.97","price_state":"stated","total_value":215761.5,"total_display":"215,761.50","total_whole":"215,762","shares_owned_after":116509.0,"shares_owned_after_display":"116,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-06","scope":"insider"},{"id":6779120,"accession":"0001209191-22-022036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-022036","line_url":"/filing/0001209191-22-022036#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4164.0,"shares_display":"4,164","price_per_share":21.8,"price_display":"21.80","price_state":"stated","total_value":90775.2,"total_display":"90,775.20","total_whole":"90,775","shares_owned_after":125509.0,"shares_owned_after_display":"125,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-01","scope":"insider"},{"id":6779115,"accession":"0001209191-22-022036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-022036","line_url":"/filing/0001209191-22-022036#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4164.0,"shares_display":"4,164","price_per_share":21.0614,"price_display":"21.06","price_state":"stated","total_value":87699.6696,"total_display":"87,699.67","total_whole":"87,700","shares_owned_after":129673.0,"shares_owned_after_display":"129,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-01","scope":"insider"},{"id":6778870,"accession":"0001209191-22-019595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-019595","line_url":"/filing/0001209191-22-019595#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3123.0,"shares_display":"3,123","price_per_share":18.94,"price_display":"18.94","price_state":"stated","total_value":59149.62,"total_display":"59,149.62","total_whole":"59,150","shares_owned_after":133837.0,"shares_owned_after_display":"133,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":6178638,"accession":"0001209191-22-015130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015130","line_url":"/filing/0001209191-22-015130#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3123.0,"shares_display":"3,123","price_per_share":19.73,"price_display":"19.73","price_state":"stated","total_value":61616.79,"total_display":"61,616.79","total_whole":"61,617","shares_owned_after":136960.0,"shares_owned_after_display":"136,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":6508583,"accession":"0001209191-22-010784","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-010784","line_url":"/filing/0001209191-22-010784#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3123.0,"shares_display":"3,123","price_per_share":18.64,"price_display":"18.64","price_state":"stated","total_value":58212.72,"total_display":"58,212.72","total_whole":"58,213","shares_owned_after":123583.0,"shares_owned_after_display":"123,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-17","scope":"insider"},{"id":6811555,"accession":"0001209191-22-006797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-006797","line_url":"/filing/0001209191-22-006797#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3123.0,"shares_display":"3,123","price_per_share":18.79,"price_display":"18.79","price_state":"stated","total_value":58681.17,"total_display":"58,681.17","total_whole":"58,681","shares_owned_after":126706.0,"shares_owned_after_display":"126,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-03","scope":"insider"},{"id":6203009,"accession":"0001209191-22-004051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004051","line_url":"/filing/0001209191-22-004051#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4168.0,"shares_display":"4,168","price_per_share":23.29,"price_display":"23.29","price_state":"stated","total_value":97072.72,"total_display":"97,072.72","total_whole":"97,073","shares_owned_after":128875.0,"shares_owned_after_display":"128,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-20","scope":"insider"},{"id":6325581,"accession":"0001209191-22-002197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002197","line_url":"/filing/0001209191-22-002197#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7168.0,"shares_display":"7,168","price_per_share":28.02,"price_display":"28.02","price_state":"stated","total_value":200847.36,"total_display":"200,847.36","total_whole":"200,847","shares_owned_after":133043.0,"shares_owned_after_display":"133,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-06","scope":"insider"},{"id":4106540,"accession":"0001209191-21-071646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-071646","line_url":"/filing/0001209191-21-071646#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":27.9506,"price_display":"27.95","price_state":"stated","total_value":83851.8,"total_display":"83,851.80","total_whole":"83,852","shares_owned_after":140211.0,"shares_owned_after_display":"140,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-30","scope":"insider"},{"id":5407193,"accession":"0001209191-21-070272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-070272","line_url":"/filing/0001209191-21-070272#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5668.0,"shares_display":"5,668","price_per_share":24.14,"price_display":"24.14","price_state":"stated","total_value":136825.52,"total_display":"136,825.52","total_whole":"136,826","shares_owned_after":143211.0,"shares_owned_after_display":"143,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":4105995,"accession":"0001209191-21-067840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067840","line_url":"/filing/0001209191-21-067840#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5668.0,"shares_display":"5,668","price_per_share":27.38,"price_display":"27.38","price_state":"stated","total_value":155189.84,"total_display":"155,189.84","total_whole":"155,190","shares_owned_after":148879.0,"shares_owned_after_display":"148,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":5501058,"accession":"0001209191-21-065149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065149","line_url":"/filing/0001209191-21-065149#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":27.97,"price_display":"27.97","price_state":"stated","total_value":41955.0,"total_display":"41,955.00","total_whole":"41,955","shares_owned_after":154547.0,"shares_owned_after_display":"154,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"},{"id":5501054,"accession":"0001209191-21-065149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065149","line_url":"/filing/0001209191-21-065149#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5668.0,"shares_display":"5,668","price_per_share":26.75,"price_display":"26.75","price_state":"stated","total_value":151619.0,"total_display":"151,619.00","total_whole":"151,619","shares_owned_after":156047.0,"shares_owned_after_display":"156,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":4343877,"accession":"0001209191-21-063679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-063679","line_url":"/filing/0001209191-21-063679#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":28.422,"price_display":"28.42","price_state":"stated","total_value":110845.8,"total_display":"110,845.80","total_whole":"110,846","shares_owned_after":161715.0,"shares_owned_after_display":"161,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-09","scope":"insider"},{"id":4343874,"accession":"0001209191-21-063679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-063679","line_url":"/filing/0001209191-21-063679#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001886575","owner_name":"Betz Stephen F.","owner_display_name":"Betz Stephen F.","owner_url":"/insider/0001886575","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":27.952,"price_display":"27.95","price_state":"stated","total_value":352195.2,"total_display":"352,195.20","total_whole":"352,195","shares_owned_after":165615.0,"shares_owned_after_display":"165,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider"}],"collapsed":true,"next_cursor":"2021-11-05|4343874","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Officer (Chief Scientific Officer)","n_filings":48,"first_seen":"2021-10-25","last_seen":"2026-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001886575","retrieved_at":"2026-08-27T00:59:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}